The RAPS NC Local Networking Group presents an in-person FDA ASCA Program session focused on the appropriate use of standards, conformity assessment, and practical strategies for premarket submissions ...
Boston Chapter In Person Event: 2026 Risks with Pharmaceutical & Medical Devices in the Supply Chain
RAPS reserves the right to cancel this program at its sole discretion. RAPS will not be responsible for travel or other costs incurred due to cancellation. All cancellation requests must be submitted ...
An advisory committee to the US Food and Drug Administration (FDA) voted 8-6 with one abstention on Thursday to recommend that two peptides – BPC-157 to treat ulcerative colitis and KPV for wound ...
The European Medicines Agency (EMA) has released a draft concept paper on planned changes to its guideline on similar biological medicinal products.
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing. I ...
Postmarketing requirements and commitments were completed for nearly nine out of ten drugs approved by the US Food and Drug Administration, with such requirements or commitments assigned at the time ...
Each year, our society honors a new class of RAPS Fellows for their noteworthy and sustained leadership contributions to their organizations, to RAPS, and to the regulatory affairs profession. Each ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results